@article{ef6e9997e0d64a60a0c77cca9a6002e3,
title = "The economics of global COVID vaccine administration during a pandemic – Why continue skin alcohol preparation as a costly but ineffective practice?",
author = "Poland, {Eric G.} and McGuire, {Darren K.} and Tamar Ratishvili and Poland, {Gregory A.}",
note = "Funding Information: GAP is the chair of a Safety Evaluation Committee for novel investigational vaccine trials being conducted by Merck Research Laboratories. GAP offers consultative advice on vaccine development to Merck & Co., Medicago, GlaxoSmithKline, Sanofi Pasteur, Emergent Biosolutions, Dynavax, Genentech, Eli Lilly and Company, Janssen Global Services LLC, Kentucky Bioprocessing, AstraZeneca, and Genevant Sciences, Inc. GAP holds patents related to vaccinia and measles peptide vaccines. GAP has received grant funding from ICW Ventures for preclinical studies on a peptide-based COVID-19 vaccine. These activities have been reviewed by the Mayo Clinic Conflict of Interest Review Board and are conducted in compliance with Mayo Clinic Conflict of Interest policies. DKM receives consultancy honoraria from Moderna, Pfizer, Janssen, Dynavax, and AstraZeneca. Other authors declare they have no conflict of interest to disclose. ",
year = "2021",
month = feb,
day = "22",
doi = "10.1016/j.vaccine.2020.12.082",
language = "English (US)",
volume = "39",
pages = "1175--1177",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "8",
}